Cargando…
Bony metastases: assessing response to therapy with whole-body diffusion MRI
There are no universally accepted methods for assessing tumour response in skeletal sites with metastatic disease; response is assessed by a combination of imaging tests, serum and urine biochemical markers and symptoms assessments. Whole-body diffusion magnetic resonance imaging excels at bone marr...
Autores principales: | Padhani, A.R., Gogbashian, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266569/ https://www.ncbi.nlm.nih.gov/pubmed/22185786 http://dx.doi.org/10.1102/1470-7330.2011.9034 |
Ejemplares similares
-
Imaging follow-up of RF ablation of lung tumours
por: Rasmussen, F., et al.
Publicado: (2011) -
Whole-body MRI and diffusion MRI
por: Padhani, Anwar R
Publicado: (2014) -
Semi-Automated Segmentation of Bone Metastases from Whole-Body MRI: Reproducibility of Apparent Diffusion Coefficient Measurements
por: Colombo, Alberto, et al.
Publicado: (2021) -
Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: recommendations for use
por: Petralia, Giuseppe, et al.
Publicado: (2021) -
Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases
por: Dresen, Raphaëla Carmen, et al.
Publicado: (2019)